[
    {
        "id": 3479,
        "drug_name": "Omecamtiv mecarbil",
        "clinical_trial_id": "NCT02929329",
        "has_trial_insight_page": 0,
        "indication": "Heart failure with reduced ejection fraction (HFrEF)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-02-28",
        "link": "https:\/\/www.globenewswire.com\/news-release\/2023\/02\/28\/2617757\/35409\/en\/Cytokinetics-Receives-Complete-Response-Letter-From-FDA-for-New-Drug-Application-for-Omecamtiv-Mecarbil.html",
        "note": "CRL issued February 28, 2023.",
        "company_entity_id": 111,
        "company_ticker": "CYTK",
        "company_name": "Cytokinetics Incorporated",
        "company_price": "78.0200",
        "company_change": 2.43,
        "company_percent_change": 3.21,
        "company_optionable": 1,
        "company_number_of_shares": 98053647,
        "price_change_sparkline": [
            [
                84.12,
                1704171600
            ],
            [
                86.64,
                1704258000
            ],
            [
                88.24,
                1704344400
            ],
            [
                93.73,
                1704430800
            ],
            [
                108.06,
                1704690000
            ],
            [
                101.97,
                1704776400
            ],
            [
                101.63,
                1704862800
            ],
            [
                84.95,
                1704949200
            ],
            [
                85.6,
                1705035600
            ],
            [
                81.19,
                1705381200
            ],
            [
                85.68,
                1705467600
            ],
            [
                82.74,
                1705554000
            ],
            [
                80.96,
                1705640400
            ],
            [
                83.69,
                1705899600
            ],
            [
                84.8,
                1705986000
            ],
            [
                81.77,
                1706072400
            ],
            [
                82.91,
                1706158800
            ],
            [
                82.74,
                1706245200
            ],
            [
                79.99,
                1706504400
            ],
            [
                78.73,
                1706590800
            ],
            [
                78.13,
                1706677200
            ],
            [
                81.25,
                1706763600
            ],
            [
                81.87,
                1706850000
            ],
            [
                80.16,
                1707109200
            ],
            [
                80.16,
                1707195600
            ],
            [
                77.12,
                1707282000
            ],
            [
                78.94,
                1707368400
            ],
            [
                76.94,
                1707454800
            ],
            [
                79.3,
                1707714000
            ],
            [
                77.03,
                1707800400
            ],
            [
                76.5,
                1707886800
            ],
            [
                78.56,
                1707973200
            ],
            [
                76.89,
                1708059600
            ],
            [
                76.89,
                1708405200
            ],
            [
                76.5,
                1708491600
            ],
            [
                75.59,
                1708578000
            ],
            [
                78.02,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3479,
        "drug_name": "Omecamtiv mecarbil",
        "clinical_trial_id": "NCT02929329",
        "has_trial_insight_page": 0,
        "indication": "Heart failure with reduced ejection fraction (HFrEF)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-02-28",
        "link": "https:\/\/www.globenewswire.com\/news-release\/2023\/02\/28\/2617757\/35409\/en\/Cytokinetics-Receives-Complete-Response-Letter-From-FDA-for-New-Drug-Application-for-Omecamtiv-Mecarbil.html",
        "note": "CRL issued February 28, 2023.",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "289.1800",
        "company_change": 4,
        "company_percent_change": 1.4,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                295.093118563779,
                1704171600
            ],
            [
                298.367631127283,
                1704258000
            ],
            [
                300.828476932583,
                1704344400
            ],
            [
                300.659789921736,
                1704430800
            ],
            [
                308.478929012769,
                1704690000
            ],
            [
                304.886887958259,
                1704776400
            ],
            [
                302.217664080736,
                1704862800
            ],
            [
                300.759017575175,
                1704949200
            ],
            [
                304.142680557463,
                1705035600
            ],
            [
                301.136082658245,
                1705381200
            ],
            [
                301.731448578882,
                1705467600
            ],
            [
                302.138281957984,
                1705554000
            ],
            [
                305.432640052176,
                1705640400
            ],
            [
                307.764489908005,
                1705899600
            ],
            [
                307.516420774406,
                1705986000
            ],
            [
                303.140481257723,
                1706072400
            ],
            [
                307.863717561444,
                1706158800
            ],
            [
                309.362055128381,
                1706245200
            ],
            [
                311.029079706165,
                1706504400
            ],
            [
                312.190043251407,
                1706590800
            ],
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6403,
        "drug_name": "ABBV-951 (foslevodopa\/foscarbidopa)",
        "clinical_trial_id": "NCT04380142",
        "has_trial_insight_page": 0,
        "indication": "Parkinson's disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-03-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/124771",
        "note": "CRL issued by FDA on March 22, 2023.",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "178.0900",
        "company_change": 1.34,
        "company_percent_change": 0.76,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                158.309045440683,
                1704171600
            ],
            [
                158.942994815493,
                1704258000
            ],
            [
                159.933540713632,
                1704344400
            ],
            [
                160.607111924367,
                1704430800
            ],
            [
                159.903824336688,
                1704690000
            ],
            [
                160.775504727051,
                1704776400
            ],
            [
                163.331113144251,
                1704862800
            ],
            [
                162.231607197316,
                1704949200
            ],
            [
                162.4,
                1705035600
            ],
            [
                161.48,
                1705381200
            ],
            [
                162.04,
                1705467600
            ],
            [
                163.3,
                1705554000
            ],
            [
                164.77,
                1705640400
            ],
            [
                165.39,
                1705899600
            ],
            [
                167.5,
                1705986000
            ],
            [
                164.22,
                1706072400
            ],
            [
                165.13,
                1706158800
            ],
            [
                164.4,
                1706245200
            ],
            [
                163.91,
                1706504400
            ],
            [
                164.92,
                1706590800
            ],
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 9608,
        "drug_name": "QD Ruxolitinib XR",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Myelofibrosis",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-03-23",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/INCY\/news\/125295",
        "note": "CRL issued by the FDA on March 23, 2023.",
        "company_entity_id": 167,
        "company_ticker": "INCY",
        "company_name": "Incyte Corporation",
        "company_price": "60.5900",
        "company_change": -0.31999999999999995,
        "company_percent_change": -0.53,
        "company_optionable": 1,
        "company_number_of_shares": 224526128,
        "price_change_sparkline": [
            [
                65.45,
                1704171600
            ],
            [
                65.51,
                1704258000
            ],
            [
                66.59,
                1704344400
            ],
            [
                65.26,
                1704430800
            ],
            [
                65.82,
                1704690000
            ],
            [
                64.38,
                1704776400
            ],
            [
                64.14,
                1704862800
            ],
            [
                63.11,
                1704949200
            ],
            [
                62.74,
                1705035600
            ],
            [
                61.34,
                1705381200
            ],
            [
                61.48,
                1705467600
            ],
            [
                61.18,
                1705554000
            ],
            [
                61.49,
                1705640400
            ],
            [
                61.5,
                1705899600
            ],
            [
                61.87,
                1705986000
            ],
            [
                60.84,
                1706072400
            ],
            [
                60.92,
                1706158800
            ],
            [
                60.64,
                1706245200
            ],
            [
                60.47,
                1706504400
            ],
            [
                59.28,
                1706590800
            ],
            [
                58.77,
                1706677200
            ],
            [
                59.16,
                1706763600
            ],
            [
                58.35,
                1706850000
            ],
            [
                58.06,
                1707109200
            ],
            [
                59.63,
                1707195600
            ],
            [
                57.34,
                1707282000
            ],
            [
                57.36,
                1707368400
            ],
            [
                57.66,
                1707454800
            ],
            [
                57.84,
                1707714000
            ],
            [
                59.34,
                1707800400
            ],
            [
                57.89,
                1707886800
            ],
            [
                58.97,
                1707973200
            ],
            [
                57.96,
                1708059600
            ],
            [
                58.82,
                1708405200
            ],
            [
                60.33,
                1708491600
            ],
            [
                60.91,
                1708578000
            ],
            [
                60.59,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4869,
        "drug_name": "Mirikizumab - (LUCENT 1)",
        "clinical_trial_id": "NCT03518086",
        "has_trial_insight_page": 0,
        "indication": "Ulcerative Colitis",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-04-13",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/129376",
        "note": "CRL announced April 13, 2023.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "769.5400",
        "company_change": -0.09999999999999998,
        "company_percent_change": -0.010000000000000009,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                591.185170245581,
                1704171600
            ],
            [
                616.641471902559,
                1704258000
            ],
            [
                613.446955616193,
                1704344400
            ],
            [
                617.490015291125,
                1704430800
            ],
            [
                624.957197110505,
                1704690000
            ],
            [
                624.408139623786,
                1704776400
            ],
            [
                629.110068282781,
                1704862800
            ],
            [
                634.630591740156,
                1704949200
            ],
            [
                641.81825338448,
                1705035600
            ],
            [
                633.482562449744,
                1705381200
            ],
            [
                627.832261768234,
                1705467600
            ],
            [
                622.281789720673,
                1705554000
            ],
            [
                627.502827276203,
                1705640400
            ],
            [
                629.798885857028,
                1705899600
            ],
            [
                628.600942249641,
                1705986000
            ],
            [
                632.614053334388,
                1706072400
            ],
            [
                626.544472390293,
                1706158800
            ],
            [
                638.154542518554,
                1706245200
            ],
            [
                643.894688970617,
                1706504400
            ],
            [
                643.874723243828,
                1706590800
            ],
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 1969,
        "drug_name": "Concizumab - (Explorer 7)",
        "clinical_trial_id": "NCT04083781",
        "has_trial_insight_page": 1,
        "indication": "Hemophilia A",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-05-04",
        "link": "https:\/\/www.novonordisk.com\/content\/dam\/nncorp\/global\/en\/investors\/pdfs\/financial-results\/2023\/Q1-2023-investor-presentation.pdf",
        "note": "CRL received in 2Q 2023.",
        "company_entity_id": 385,
        "company_ticker": "NVO",
        "company_name": "Novo Nordisk A\/S",
        "company_price": "123.4500",
        "company_change": -1.0699999999999998,
        "company_percent_change": -0.86,
        "company_optionable": 1,
        "company_number_of_shares": 4510000000,
        "price_change_sparkline": [
            [
                102.11,
                1704171600
            ],
            [
                103.62,
                1704258000
            ],
            [
                107.63,
                1704344400
            ],
            [
                105.98,
                1704430800
            ],
            [
                106.4,
                1704690000
            ],
            [
                106.95,
                1704776400
            ],
            [
                108.67,
                1704862800
            ],
            [
                106.69,
                1704949200
            ],
            [
                107.16,
                1705035600
            ],
            [
                106.35,
                1705381200
            ],
            [
                106.68,
                1705467600
            ],
            [
                107.55,
                1705554000
            ],
            [
                106.96,
                1705640400
            ],
            [
                105.49,
                1705899600
            ],
            [
                105.37,
                1705986000
            ],
            [
                105.21,
                1706072400
            ],
            [
                105.68,
                1706158800
            ],
            [
                108.07,
                1706245200
            ],
            [
                109.02,
                1706504400
            ],
            [
                109.02,
                1706590800
            ],
            [
                114.74,
                1706677200
            ],
            [
                115.79,
                1706763600
            ],
            [
                113.7,
                1706850000
            ],
            [
                118.26,
                1707109200
            ],
            [
                117.61,
                1707195600
            ],
            [
                118.66,
                1707282000
            ],
            [
                118.39,
                1707368400
            ],
            [
                121.2,
                1707454800
            ],
            [
                120.53,
                1707714000
            ],
            [
                119.99,
                1707800400
            ],
            [
                123.29,
                1707886800
            ],
            [
                121.75,
                1707973200
            ],
            [
                124.01,
                1708059600
            ],
            [
                121.45,
                1708405200
            ],
            [
                120.93,
                1708491600
            ],
            [
                124.52,
                1708578000
            ],
            [
                123.45,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 8931,
        "drug_name": "Concizumab",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Hemophilia A and B",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-05-04",
        "link": "https:\/\/www.novonordisk.com\/content\/dam\/nncorp\/global\/en\/investors\/pdfs\/financial-results\/2023\/Q1-2023-investor-presentation.pdf",
        "note": "CRL received noted May 4, 2023.",
        "company_entity_id": 385,
        "company_ticker": "NVO",
        "company_name": "Novo Nordisk A\/S",
        "company_price": "123.4500",
        "company_change": -1.0699999999999998,
        "company_percent_change": -0.86,
        "company_optionable": 1,
        "company_number_of_shares": 4510000000,
        "price_change_sparkline": [
            [
                102.11,
                1704171600
            ],
            [
                103.62,
                1704258000
            ],
            [
                107.63,
                1704344400
            ],
            [
                105.98,
                1704430800
            ],
            [
                106.4,
                1704690000
            ],
            [
                106.95,
                1704776400
            ],
            [
                108.67,
                1704862800
            ],
            [
                106.69,
                1704949200
            ],
            [
                107.16,
                1705035600
            ],
            [
                106.35,
                1705381200
            ],
            [
                106.68,
                1705467600
            ],
            [
                107.55,
                1705554000
            ],
            [
                106.96,
                1705640400
            ],
            [
                105.49,
                1705899600
            ],
            [
                105.37,
                1705986000
            ],
            [
                105.21,
                1706072400
            ],
            [
                105.68,
                1706158800
            ],
            [
                108.07,
                1706245200
            ],
            [
                109.02,
                1706504400
            ],
            [
                109.02,
                1706590800
            ],
            [
                114.74,
                1706677200
            ],
            [
                115.79,
                1706763600
            ],
            [
                113.7,
                1706850000
            ],
            [
                118.26,
                1707109200
            ],
            [
                117.61,
                1707195600
            ],
            [
                118.66,
                1707282000
            ],
            [
                118.39,
                1707368400
            ],
            [
                121.2,
                1707454800
            ],
            [
                120.53,
                1707714000
            ],
            [
                119.99,
                1707800400
            ],
            [
                123.29,
                1707886800
            ],
            [
                121.75,
                1707973200
            ],
            [
                124.01,
                1708059600
            ],
            [
                121.45,
                1708405200
            ],
            [
                120.93,
                1708491600
            ],
            [
                124.52,
                1708578000
            ],
            [
                123.45,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 8099,
        "drug_name": "Landiolol",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Supraventricular tachycardia (SVT) - atrial fibrillation and atrial flutter",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-05-31",
        "link": "https:\/\/investor.eagleus.com\/static-files\/76a095b6-c39a-4ae4-b652-50ccaa5df833",
        "note": "CRL received on May 31, 2023.",
        "company_entity_id": 128,
        "company_ticker": "EGRX",
        "company_name": "Eagle Pharmaceuticals Inc.",
        "company_price": "6.2500",
        "company_change": 0.38,
        "company_percent_change": 6.47,
        "company_optionable": 1,
        "company_number_of_shares": 12986971,
        "price_change_sparkline": [
            [
                5.66,
                1704171600
            ],
            [
                5.23,
                1704258000
            ],
            [
                5.23,
                1704344400
            ],
            [
                5.13,
                1704430800
            ],
            [
                4.91,
                1704690000
            ],
            [
                4.84,
                1704776400
            ],
            [
                4.78,
                1704862800
            ],
            [
                4.5,
                1704949200
            ],
            [
                4.53,
                1705035600
            ],
            [
                4.26,
                1705381200
            ],
            [
                4.36,
                1705467600
            ],
            [
                4.53,
                1705554000
            ],
            [
                4.48,
                1705640400
            ],
            [
                4.42,
                1705899600
            ],
            [
                4.73,
                1705986000
            ],
            [
                4.94,
                1706072400
            ],
            [
                5.3,
                1706158800
            ],
            [
                5.41,
                1706245200
            ],
            [
                5.51,
                1706504400
            ],
            [
                5.48,
                1706590800
            ],
            [
                5.86,
                1706677200
            ],
            [
                6.08,
                1706763600
            ],
            [
                5.85,
                1706850000
            ],
            [
                5.6,
                1707109200
            ],
            [
                4.9,
                1707195600
            ],
            [
                5.165,
                1707282000
            ],
            [
                5.32,
                1707368400
            ],
            [
                5.32,
                1707454800
            ],
            [
                5.6,
                1707714000
            ],
            [
                5.21,
                1707800400
            ],
            [
                5.25,
                1707886800
            ],
            [
                5.85,
                1707973200
            ],
            [
                5.97,
                1708059600
            ],
            [
                5.99,
                1708405200
            ],
            [
                6.23,
                1708491600
            ],
            [
                5.87,
                1708578000
            ],
            [
                6.25,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6012,
        "drug_name": "ADX-2191 - (GUARD)",
        "clinical_trial_id": "NCT04136366",
        "has_trial_insight_page": 1,
        "indication": "Proliferative vitreoretinopathy (PVR)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-06-21",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ALDX\/news\/142815",
        "note": "CRL issued on June 21, 2023. Aldeyra plans to have a Type-C meeting on 2H 2023.",
        "company_entity_id": 29,
        "company_ticker": "ALDX",
        "company_name": "Aldeyra Therapeutics Inc.",
        "company_price": "3.4900",
        "company_change": -0.050000000000000044,
        "company_percent_change": -1.4100000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 58822083,
        "price_change_sparkline": [
            [
                3.54,
                1704171600
            ],
            [
                3.35,
                1704258000
            ],
            [
                3.34,
                1704344400
            ],
            [
                3.23,
                1704430800
            ],
            [
                3.35,
                1704690000
            ],
            [
                3.37,
                1704776400
            ],
            [
                3.34,
                1704862800
            ],
            [
                3.2,
                1704949200
            ],
            [
                3.21,
                1705035600
            ],
            [
                3.27,
                1705381200
            ],
            [
                3.2,
                1705467600
            ],
            [
                3.04,
                1705554000
            ],
            [
                3.08,
                1705640400
            ],
            [
                3.09,
                1705899600
            ],
            [
                3.07,
                1705986000
            ],
            [
                3,
                1706072400
            ],
            [
                3.04,
                1706158800
            ],
            [
                3.04,
                1706245200
            ],
            [
                3.38,
                1706504400
            ],
            [
                3.23,
                1706590800
            ],
            [
                3.13,
                1706677200
            ],
            [
                3.19,
                1706763600
            ],
            [
                3.18,
                1706850000
            ],
            [
                3.12,
                1707109200
            ],
            [
                3.34,
                1707195600
            ],
            [
                3.24,
                1707282000
            ],
            [
                3.23,
                1707368400
            ],
            [
                3.3,
                1707454800
            ],
            [
                3.39,
                1707714000
            ],
            [
                3.18,
                1707800400
            ],
            [
                3.4,
                1707886800
            ],
            [
                3.6,
                1707973200
            ],
            [
                3.59,
                1708059600
            ],
            [
                3.44,
                1708405200
            ],
            [
                3.35,
                1708491600
            ],
            [
                3.54,
                1708578000
            ],
            [
                3.49,
                1708664400
            ]
        ],
        "statuses": [
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 6847,
        "drug_name": "Dehydrated alcohol injection (DS-100)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Methanol poisoning",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-06-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ETON\/news\/143985",
        "note": "CRL Announced on June 28, 2023.",
        "company_entity_id": 611,
        "company_ticker": "ETON",
        "company_name": "Eton Pharmaceuticals Inc.",
        "company_price": "4.4700",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 1,
        "company_number_of_shares": 25658396,
        "price_change_sparkline": [
            [
                4.59,
                1704171600
            ],
            [
                4.63,
                1704258000
            ],
            [
                4.64,
                1704344400
            ],
            [
                4.34,
                1704430800
            ],
            [
                5.03,
                1704690000
            ],
            [
                4.93,
                1704776400
            ],
            [
                4.86,
                1704862800
            ],
            [
                4.74,
                1704949200
            ],
            [
                4.37,
                1705035600
            ],
            [
                4.09,
                1705381200
            ],
            [
                4.14,
                1705467600
            ],
            [
                4.08,
                1705554000
            ],
            [
                4.14,
                1705640400
            ],
            [
                4.39,
                1705899600
            ],
            [
                4.47,
                1705986000
            ],
            [
                4.45,
                1706072400
            ],
            [
                4.44,
                1706158800
            ],
            [
                4.56,
                1706245200
            ],
            [
                4.71,
                1706504400
            ],
            [
                4.74,
                1706590800
            ],
            [
                4.67,
                1706677200
            ],
            [
                4.6,
                1706763600
            ],
            [
                4.49,
                1706850000
            ],
            [
                4.58,
                1707109200
            ],
            [
                4.72,
                1707195600
            ],
            [
                4.58,
                1707282000
            ],
            [
                4.41,
                1707368400
            ],
            [
                4.41,
                1707454800
            ],
            [
                4.41,
                1707714000
            ],
            [
                4.42,
                1707800400
            ],
            [
                4.39,
                1707886800
            ],
            [
                4.59,
                1707973200
            ],
            [
                4.4,
                1708059600
            ],
            [
                4.36,
                1708405200
            ],
            [
                4.45,
                1708491600
            ],
            [
                4.47,
                1708578000
            ],
            [
                4.47,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4732,
        "drug_name": "IPX203 - (RISE-PD)",
        "clinical_trial_id": "NCT03670953",
        "has_trial_insight_page": 0,
        "indication": "Parkinson's disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-07-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMRX\/news\/144778",
        "note": "CRL issued by the FDA on July 3, 2023.",
        "company_entity_id": 543,
        "company_ticker": "AMRX",
        "company_name": "Amneal Pharmaceuticals Inc.",
        "company_price": "5.8000",
        "company_change": 0.11,
        "company_percent_change": 1.9300000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 306544199,
        "price_change_sparkline": [
            [
                5.98,
                1704171600
            ],
            [
                5.86,
                1704258000
            ],
            [
                5.9,
                1704344400
            ],
            [
                5.99,
                1704430800
            ],
            [
                5.94,
                1704690000
            ],
            [
                5.69,
                1704776400
            ],
            [
                5.51,
                1704862800
            ],
            [
                5.45,
                1704949200
            ],
            [
                5.4,
                1705035600
            ],
            [
                5.35,
                1705381200
            ],
            [
                5.24,
                1705467600
            ],
            [
                5.31,
                1705554000
            ],
            [
                5.4,
                1705640400
            ],
            [
                5.47,
                1705899600
            ],
            [
                5.48,
                1705986000
            ],
            [
                5.43,
                1706072400
            ],
            [
                5.47,
                1706158800
            ],
            [
                5.49,
                1706245200
            ],
            [
                5.76,
                1706504400
            ],
            [
                5.51,
                1706590800
            ],
            [
                5.35,
                1706677200
            ],
            [
                5.51,
                1706763600
            ],
            [
                5.52,
                1706850000
            ],
            [
                5.52,
                1707109200
            ],
            [
                5.6,
                1707195600
            ],
            [
                5.36,
                1707282000
            ],
            [
                5.46,
                1707368400
            ],
            [
                5.57,
                1707454800
            ],
            [
                5.85,
                1707714000
            ],
            [
                5.6,
                1707800400
            ],
            [
                5.82,
                1707886800
            ],
            [
                5.89,
                1707973200
            ],
            [
                5.9,
                1708059600
            ],
            [
                5.78,
                1708405200
            ],
            [
                5.73,
                1708491600
            ],
            [
                5.69,
                1708578000
            ],
            [
                5.8,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 8207,
        "drug_name": "LYMPHIR (Denileukin diftitox)",
        "clinical_trial_id": "NCT01871727",
        "has_trial_insight_page": 1,
        "indication": "CTCL non-Hodgkin lymphoma",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-07-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CTXR\/news\/149406",
        "note": "CRL received on July 29, 2023.",
        "company_entity_id": 489,
        "company_ticker": "CTXR",
        "company_name": "Citius Pharmaceuticals Inc.",
        "company_price": "0.7600",
        "company_change": -0.030000000000000027,
        "company_percent_change": -3.8,
        "company_optionable": 1,
        "company_number_of_shares": 159094781,
        "price_change_sparkline": [
            [
                0.8087,
                1704171600
            ],
            [
                0.783,
                1704258000
            ],
            [
                0.7792,
                1704344400
            ],
            [
                0.7606,
                1704430800
            ],
            [
                0.7647,
                1704690000
            ],
            [
                0.7465,
                1704776400
            ],
            [
                0.746,
                1704862800
            ],
            [
                0.7409,
                1704949200
            ],
            [
                0.75,
                1705035600
            ],
            [
                0.75,
                1705381200
            ],
            [
                0.7652,
                1705467600
            ],
            [
                0.75,
                1705554000
            ],
            [
                0.721,
                1705640400
            ],
            [
                0.7,
                1705899600
            ],
            [
                0.6736,
                1705986000
            ],
            [
                0.6401,
                1706072400
            ],
            [
                0.6531,
                1706158800
            ],
            [
                0.6802,
                1706245200
            ],
            [
                0.6687,
                1706504400
            ],
            [
                0.625,
                1706590800
            ],
            [
                0.621,
                1706677200
            ],
            [
                0.6368,
                1706763600
            ],
            [
                0.6256,
                1706850000
            ],
            [
                0.6,
                1707109200
            ],
            [
                0.6103,
                1707195600
            ],
            [
                0.6117,
                1707282000
            ],
            [
                0.6117,
                1707368400
            ],
            [
                0.658,
                1707454800
            ],
            [
                0.7167,
                1707714000
            ],
            [
                0.68,
                1707800400
            ],
            [
                0.7719,
                1707886800
            ],
            [
                0.8423,
                1707973200
            ],
            [
                0.7951,
                1708059600
            ],
            [
                0.75,
                1708405200
            ],
            [
                0.7699,
                1708491600
            ],
            [
                0.79,
                1708578000
            ],
            [
                0.76,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3253,
        "drug_name": "Remestemcel-L (MSC-100-IV)",
        "clinical_trial_id": "NCT00562497",
        "has_trial_insight_page": 0,
        "indication": "Steroid-refractory acute graft versus host disease (aGVHD) in children",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-08-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MESO\/news\/150924",
        "note": "Additional CRL announced August 3, 2023.",
        "company_entity_id": 196,
        "company_ticker": "MESO",
        "company_name": "Mesoblast Limited",
        "company_price": "2.0900",
        "company_change": 0.03,
        "company_percent_change": 1.46,
        "company_optionable": 1,
        "company_number_of_shares": 101534224,
        "price_change_sparkline": [
            [
                2.16,
                1704171600
            ],
            [
                2.08,
                1704258000
            ],
            [
                2.08,
                1704344400
            ],
            [
                2.1,
                1704430800
            ],
            [
                2.08,
                1704690000
            ],
            [
                2.08,
                1704776400
            ],
            [
                1.93,
                1704862800
            ],
            [
                1.88,
                1704949200
            ],
            [
                1.95,
                1705035600
            ],
            [
                1.83,
                1705381200
            ],
            [
                1.74,
                1705467600
            ],
            [
                1.72,
                1705554000
            ],
            [
                1.92,
                1705640400
            ],
            [
                1.82,
                1705899600
            ],
            [
                1.8,
                1705986000
            ],
            [
                1.77,
                1706072400
            ],
            [
                1.79,
                1706158800
            ],
            [
                1.83,
                1706245200
            ],
            [
                1.865,
                1706504400
            ],
            [
                1.83,
                1706590800
            ],
            [
                1.76,
                1706677200
            ],
            [
                1.79,
                1706763600
            ],
            [
                1.77,
                1706850000
            ],
            [
                1.8,
                1707109200
            ],
            [
                1.81,
                1707195600
            ],
            [
                1.79,
                1707282000
            ],
            [
                1.8,
                1707368400
            ],
            [
                1.82,
                1707454800
            ],
            [
                1.8927,
                1707714000
            ],
            [
                1.85,
                1707800400
            ],
            [
                1.93,
                1707886800
            ],
            [
                2.045,
                1707973200
            ],
            [
                2.02,
                1708059600
            ],
            [
                2.01,
                1708405200
            ],
            [
                2.03,
                1708491600
            ],
            [
                2.06,
                1708578000
            ],
            [
                2.1,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 10589,
        "drug_name": "Zuranolone (SAGE-217)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Major depressive disorder (MDD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-08-04",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SAGE\/news\/151119",
        "note": "CRL issued August 4, 2023.",
        "company_entity_id": 273,
        "company_ticker": "SAGE",
        "company_name": "Sage Therapeutics Inc.",
        "company_price": "22.0100",
        "company_change": -0.24,
        "company_percent_change": -1.08,
        "company_optionable": 1,
        "company_number_of_shares": 60106687,
        "price_change_sparkline": [
            [
                22.48,
                1704171600
            ],
            [
                21.67,
                1704258000
            ],
            [
                21.13,
                1704344400
            ],
            [
                21.47,
                1704430800
            ],
            [
                25.1,
                1704690000
            ],
            [
                26.37,
                1704776400
            ],
            [
                25.4,
                1704862800
            ],
            [
                26.89,
                1704949200
            ],
            [
                26.55,
                1705035600
            ],
            [
                26.4,
                1705381200
            ],
            [
                26.95,
                1705467600
            ],
            [
                26.02,
                1705554000
            ],
            [
                26.01,
                1705640400
            ],
            [
                26.27,
                1705899600
            ],
            [
                26.71,
                1705986000
            ],
            [
                26.51,
                1706072400
            ],
            [
                26.27,
                1706158800
            ],
            [
                26.36,
                1706245200
            ],
            [
                26.54,
                1706504400
            ],
            [
                25.9,
                1706590800
            ],
            [
                25.64,
                1706677200
            ],
            [
                26,
                1706763600
            ],
            [
                24.77,
                1706850000
            ],
            [
                24.27,
                1707109200
            ],
            [
                24.72,
                1707195600
            ],
            [
                23.91,
                1707282000
            ],
            [
                23.78,
                1707368400
            ],
            [
                23.69,
                1707454800
            ],
            [
                23.83,
                1707714000
            ],
            [
                23.02,
                1707800400
            ],
            [
                25.75,
                1707886800
            ],
            [
                25.41,
                1707973200
            ],
            [
                23.27,
                1708059600
            ],
            [
                22.17,
                1708405200
            ],
            [
                22.2,
                1708491600
            ],
            [
                22.25,
                1708578000
            ],
            [
                22.01,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 10589,
        "drug_name": "Zuranolone (SAGE-217)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Major depressive disorder (MDD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-08-04",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SAGE\/news\/151119",
        "note": "CRL issued August 4, 2023.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "223.3200",
        "company_change": 0.84,
        "company_percent_change": 0.38,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                267.71,
                1704171600
            ],
            [
                263.43,
                1704258000
            ],
            [
                260.28,
                1704344400
            ],
            [
                257.88,
                1704430800
            ],
            [
                257.98,
                1704690000
            ],
            [
                255.84,
                1704776400
            ],
            [
                254.23,
                1704862800
            ],
            [
                247.21,
                1704949200
            ],
            [
                248.12,
                1705035600
            ],
            [
                246.19,
                1705381200
            ],
            [
                245.27,
                1705467600
            ],
            [
                246.97,
                1705554000
            ],
            [
                249.96,
                1705640400
            ],
            [
                248.3,
                1705899600
            ],
            [
                251.68,
                1705986000
            ],
            [
                247.16,
                1706072400
            ],
            [
                246.21,
                1706158800
            ],
            [
                244.82,
                1706245200
            ],
            [
                247.52,
                1706504400
            ],
            [
                247.08,
                1706590800
            ],
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6222,
        "drug_name": "Avasopasem (GC4419) - (ROMAN)",
        "clinical_trial_id": "NCT03689712",
        "has_trial_insight_page": 1,
        "indication": "Severe Oral Mucositis (SOM)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-08-09",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GRTX\/news\/152114",
        "note": "FDA issued a Complete Response Letter (CRL), noted August 9, 2023.",
        "company_entity_id": 719,
        "company_ticker": "GRTX",
        "company_name": "Galera Therapeutics Inc.",
        "company_price": "0.1860",
        "company_change": -0.020000000000000018,
        "company_percent_change": -11.43,
        "company_optionable": 1,
        "company_number_of_shares": 54392170,
        "price_change_sparkline": [
            [
                0.152,
                1704171600
            ],
            [
                0.151,
                1704258000
            ],
            [
                0.15,
                1704344400
            ],
            [
                0.1499,
                1704430800
            ],
            [
                0.1492,
                1704690000
            ],
            [
                0.211,
                1704776400
            ],
            [
                0.194,
                1704862800
            ],
            [
                0.2275,
                1704949200
            ],
            [
                0.215,
                1705035600
            ],
            [
                0.2107,
                1705381200
            ],
            [
                0.2097,
                1705467600
            ],
            [
                0.1889,
                1705554000
            ],
            [
                0.175,
                1705640400
            ],
            [
                0.1799,
                1705899600
            ],
            [
                0.1798,
                1705986000
            ],
            [
                0.1805,
                1706072400
            ],
            [
                0.174,
                1706158800
            ],
            [
                0.1775,
                1706245200
            ],
            [
                0.18,
                1706504400
            ],
            [
                0.185,
                1706590800
            ],
            [
                0.179,
                1706677200
            ],
            [
                0.1795,
                1706763600
            ],
            [
                0.1748,
                1706850000
            ],
            [
                0.1677,
                1707109200
            ],
            [
                0.1721,
                1707195600
            ],
            [
                0.17,
                1707282000
            ],
            [
                0.1704,
                1707368400
            ],
            [
                0.171,
                1707454800
            ],
            [
                0.1728,
                1707714000
            ],
            [
                0.174,
                1707800400
            ],
            [
                0.174,
                1707886800
            ],
            [
                0.1825,
                1707973200
            ],
            [
                0.1866,
                1708059600
            ],
            [
                0.1778,
                1708405200
            ],
            [
                0.186,
                1708491600
            ],
            [
                0.21,
                1708578000
            ],
            [
                0.186,
                1708664400
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            },
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 6883,
        "drug_name": "ULTOMIRIS (ravulizumab-cwvz) - (CHAMPION-NMOSD)",
        "clinical_trial_id": "NCT04201262",
        "has_trial_insight_page": 1,
        "indication": "Neuromyelitis Optica Spectrum Disorder (NMOSD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-09-06",
        "link": "https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2023\/update-on-us-review-of-ultomiris-for-nmosd.html",
        "note": "CRL issued on September 6, 2023.",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "65.8300",
        "company_change": 1.7,
        "company_percent_change": 2.65,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                67.3653075328265,
                1704171600
            ],
            [
                67.2865176994548,
                1704258000
            ],
            [
                67.7395592413422,
                1704344400
            ],
            [
                67.3456100744836,
                1704430800
            ],
            [
                68.1630545957153,
                1704690000
            ],
            [
                67.8675927205713,
                1704776400
            ],
            [
                68.517608845888,
                1704862800
            ],
            [
                68.1335084082009,
                1704949200
            ],
            [
                68.3698779083161,
                1705035600
            ],
            [
                66.2524011364509,
                1705381200
            ],
            [
                65.2478307609614,
                1705467600
            ],
            [
                65.513746448591,
                1705554000
            ],
            [
                65.5334439069339,
                1705640400
            ],
            [
                66.1243676572218,
                1705899600
            ],
            [
                65.7402672195347,
                1705986000
            ],
            [
                65.5925362819627,
                1706072400
            ],
            [
                66.0061829071642,
                1706158800
            ],
            [
                66.084972740536,
                1706245200
            ],
            [
                66.1736113030792,
                1706504400
            ],
            [
                66.1834600322506,
                1706590800
            ],
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 8731,
        "drug_name": "Lebrikizumab - (ADhere)",
        "clinical_trial_id": "NCT04250337",
        "has_trial_insight_page": 0,
        "indication": "Moderate-to-severe atopic dermatitis (AD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-10-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/161849",
        "note": "CRL issued October 2, 2023.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "769.5400",
        "company_change": -0.09999999999999998,
        "company_percent_change": -0.010000000000000009,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                591.185170245581,
                1704171600
            ],
            [
                616.641471902559,
                1704258000
            ],
            [
                613.446955616193,
                1704344400
            ],
            [
                617.490015291125,
                1704430800
            ],
            [
                624.957197110505,
                1704690000
            ],
            [
                624.408139623786,
                1704776400
            ],
            [
                629.110068282781,
                1704862800
            ],
            [
                634.630591740156,
                1704949200
            ],
            [
                641.81825338448,
                1705035600
            ],
            [
                633.482562449744,
                1705381200
            ],
            [
                627.832261768234,
                1705467600
            ],
            [
                622.281789720673,
                1705554000
            ],
            [
                627.502827276203,
                1705640400
            ],
            [
                629.798885857028,
                1705899600
            ],
            [
                628.600942249641,
                1705986000
            ],
            [
                632.614053334388,
                1706072400
            ],
            [
                626.544472390293,
                1706158800
            ],
            [
                638.154542518554,
                1706245200
            ],
            [
                643.894688970617,
                1706504400
            ],
            [
                643.874723243828,
                1706590800
            ],
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 10722,
        "drug_name": "Liquid botulinum toxin type A (QM-1114)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Glabellar and lateral canthal lines",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-10-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/IPSEY\/news\/162309",
        "note": "CRL received October 3, 2023.",
        "company_entity_id": 2251,
        "company_ticker": "IPSEY",
        "company_name": "Ipsen ADR",
        "company_price": "28.4675",
        "company_change": 0.17,
        "company_percent_change": 0.61,
        "company_optionable": 0,
        "company_number_of_shares": 328117684,
        "price_change_sparkline": [
            [
                29.94,
                1704171600
            ],
            [
                29.94,
                1704258000
            ],
            [
                30.08,
                1704344400
            ],
            [
                29.65,
                1704430800
            ],
            [
                29.92,
                1704690000
            ],
            [
                29.375,
                1704776400
            ],
            [
                29.65,
                1704862800
            ],
            [
                28.335,
                1704949200
            ],
            [
                28.51,
                1705035600
            ],
            [
                28.64,
                1705381200
            ],
            [
                28.67,
                1705467600
            ],
            [
                28.67,
                1705554000
            ],
            [
                28.64,
                1705640400
            ],
            [
                29.24,
                1705899600
            ],
            [
                28.27,
                1705986000
            ],
            [
                28.27,
                1706072400
            ],
            [
                28.27,
                1706158800
            ],
            [
                29.71,
                1706245200
            ],
            [
                29.095,
                1706504400
            ],
            [
                29.095,
                1706590800
            ],
            [
                29.095,
                1706677200
            ],
            [
                28.85,
                1706763600
            ],
            [
                28.85,
                1706850000
            ],
            [
                28,
                1707109200
            ],
            [
                28.28,
                1707195600
            ],
            [
                29.2,
                1707282000
            ],
            [
                28.495,
                1707368400
            ],
            [
                28.664,
                1707454800
            ],
            [
                28.664,
                1707714000
            ],
            [
                28.22,
                1707800400
            ],
            [
                27.82,
                1707886800
            ],
            [
                28.5,
                1707973200
            ],
            [
                28.405,
                1708059600
            ],
            [
                28.874,
                1708405200
            ],
            [
                28.0425,
                1708491600
            ],
            [
                28.295,
                1708578000
            ],
            [
                28.468,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5714,
        "drug_name": "ONPATTRO (patisiran) - (APOLLO-B)",
        "clinical_trial_id": "NCT03997383",
        "has_trial_insight_page": 1,
        "indication": "Wild-type ATTR amyloidosis patients with cardiomyopathy",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-10-09",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ALNY\/news\/163131",
        "note": "CRL issued by the FDA on October 9, 2023. As a result of the CRL, the Company will no longer pursue an expanded indication for patisiran in the US.",
        "company_entity_id": 32,
        "company_ticker": "ALNY",
        "company_name": "Alnylam Pharmaceuticals Inc.",
        "company_price": "157.6500",
        "company_change": -5.16,
        "company_percent_change": -3.17,
        "company_optionable": 1,
        "company_number_of_shares": 125945793,
        "price_change_sparkline": [
            [
                194.93,
                1704171600
            ],
            [
                190.64,
                1704258000
            ],
            [
                192.31,
                1704344400
            ],
            [
                189.38,
                1704430800
            ],
            [
                196.83,
                1704690000
            ],
            [
                198.2,
                1704776400
            ],
            [
                196.61,
                1704862800
            ],
            [
                195.08,
                1704949200
            ],
            [
                193.39,
                1705035600
            ],
            [
                187.49,
                1705381200
            ],
            [
                188.555,
                1705467600
            ],
            [
                185.95,
                1705554000
            ],
            [
                184.03,
                1705640400
            ],
            [
                183.92,
                1705899600
            ],
            [
                189.7,
                1705986000
            ],
            [
                185.2,
                1706072400
            ],
            [
                183.93,
                1706158800
            ],
            [
                179.62,
                1706245200
            ],
            [
                180.96,
                1706504400
            ],
            [
                180.12,
                1706590800
            ],
            [
                172.91,
                1706677200
            ],
            [
                174.92,
                1706763600
            ],
            [
                173.06,
                1706850000
            ],
            [
                170.7,
                1707109200
            ],
            [
                172.18,
                1707195600
            ],
            [
                168.6,
                1707282000
            ],
            [
                169.5,
                1707368400
            ],
            [
                170.03,
                1707454800
            ],
            [
                169.34,
                1707714000
            ],
            [
                162,
                1707800400
            ],
            [
                164.15,
                1707886800
            ],
            [
                147.43,
                1707973200
            ],
            [
                147,
                1708059600
            ],
            [
                149.69,
                1708405200
            ],
            [
                154.74,
                1708491600
            ],
            [
                162.81,
                1708578000
            ],
            [
                157.65,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 9025,
        "drug_name": "Dupixent (dupilumab) - (LIBERTY-CUPID)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Chronic spontaneous urticaria (CSU)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-10-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/REGN\/news\/165347",
        "note": "CRL issued by the FDA, noted  October 20, 2023.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "981.2000",
        "company_change": 16.31,
        "company_percent_change": 1.69,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                905,
                1704171600
            ],
            [
                917.56,
                1704258000
            ],
            [
                912.17,
                1704344400
            ],
            [
                913.17,
                1704430800
            ],
            [
                902.88,
                1704690000
            ],
            [
                902.69,
                1704776400
            ],
            [
                906.16,
                1704862800
            ],
            [
                915.97,
                1704949200
            ],
            [
                933.2,
                1705035600
            ],
            [
                937.32,
                1705381200
            ],
            [
                929.13,
                1705467600
            ],
            [
                930,
                1705554000
            ],
            [
                933.4,
                1705640400
            ],
            [
                942.83,
                1705899600
            ],
            [
                954.58,
                1705986000
            ],
            [
                948.24,
                1706072400
            ],
            [
                948.87,
                1706158800
            ],
            [
                940.05,
                1706245200
            ],
            [
                955.8,
                1706504400
            ],
            [
                959.73,
                1706590800
            ],
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 9025,
        "drug_name": "Dupixent (dupilumab) - (LIBERTY-CUPID)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Chronic spontaneous urticaria (CSU)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-10-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/REGN\/news\/165347",
        "note": "CRL issued by the FDA, noted  October 20, 2023.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.7700",
        "company_change": 0.97,
        "company_percent_change": 2.03,
        "company_optionable": 1,
        "company_number_of_shares": 2521671464,
        "price_change_sparkline": [
            [
                50,
                1704171600
            ],
            [
                50.61,
                1704258000
            ],
            [
                51.01,
                1704344400
            ],
            [
                51.21,
                1704430800
            ],
            [
                51.99,
                1704690000
            ],
            [
                51.76,
                1704776400
            ],
            [
                52.41,
                1704862800
            ],
            [
                52.48,
                1704949200
            ],
            [
                52.21,
                1705035600
            ],
            [
                51.56,
                1705381200
            ],
            [
                51.64,
                1705467600
            ],
            [
                51.88,
                1705554000
            ],
            [
                51.03,
                1705640400
            ],
            [
                50.83,
                1705899600
            ],
            [
                49.89,
                1705986000
            ],
            [
                49.89,
                1706072400
            ],
            [
                49.88,
                1706158800
            ],
            [
                50.14,
                1706245200
            ],
            [
                50.28,
                1706504400
            ],
            [
                50.25,
                1706590800
            ],
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4478,
        "drug_name": "Lebrikizumab (ADvocate 1 and ADvocate 2)",
        "clinical_trial_id": "NCT04146363",
        "has_trial_insight_page": 1,
        "indication": "Atopic Dermatitis",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-11-02",
        "link": "https:\/\/investor.lilly.com\/static-files\/a3f7198b-e8be-4994-ae59-77272b5c8702",
        "note": "CRL received in the US, noted November 2, 2023.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "769.5400",
        "company_change": -0.09999999999999998,
        "company_percent_change": -0.010000000000000009,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                591.185170245581,
                1704171600
            ],
            [
                616.641471902559,
                1704258000
            ],
            [
                613.446955616193,
                1704344400
            ],
            [
                617.490015291125,
                1704430800
            ],
            [
                624.957197110505,
                1704690000
            ],
            [
                624.408139623786,
                1704776400
            ],
            [
                629.110068282781,
                1704862800
            ],
            [
                634.630591740156,
                1704949200
            ],
            [
                641.81825338448,
                1705035600
            ],
            [
                633.482562449744,
                1705381200
            ],
            [
                627.832261768234,
                1705467600
            ],
            [
                622.281789720673,
                1705554000
            ],
            [
                627.502827276203,
                1705640400
            ],
            [
                629.798885857028,
                1705899600
            ],
            [
                628.600942249641,
                1705986000
            ],
            [
                632.614053334388,
                1706072400
            ],
            [
                626.544472390293,
                1706158800
            ],
            [
                638.154542518554,
                1706245200
            ],
            [
                643.894688970617,
                1706504400
            ],
            [
                643.874723243828,
                1706590800
            ],
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3096,
        "drug_name": "Reproxalap (ADX-102) - (TRANQUILITY)",
        "clinical_trial_id": "NCT04674358",
        "has_trial_insight_page": 0,
        "indication": "Dry eye disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-11-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ALDX\/news\/171997",
        "note": "CRL issued on November 27, 2023.",
        "company_entity_id": 29,
        "company_ticker": "ALDX",
        "company_name": "Aldeyra Therapeutics Inc.",
        "company_price": "3.4900",
        "company_change": -0.050000000000000044,
        "company_percent_change": -1.4100000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 58822083,
        "price_change_sparkline": [
            [
                3.54,
                1704171600
            ],
            [
                3.35,
                1704258000
            ],
            [
                3.34,
                1704344400
            ],
            [
                3.23,
                1704430800
            ],
            [
                3.35,
                1704690000
            ],
            [
                3.37,
                1704776400
            ],
            [
                3.34,
                1704862800
            ],
            [
                3.2,
                1704949200
            ],
            [
                3.21,
                1705035600
            ],
            [
                3.27,
                1705381200
            ],
            [
                3.2,
                1705467600
            ],
            [
                3.04,
                1705554000
            ],
            [
                3.08,
                1705640400
            ],
            [
                3.09,
                1705899600
            ],
            [
                3.07,
                1705986000
            ],
            [
                3,
                1706072400
            ],
            [
                3.04,
                1706158800
            ],
            [
                3.04,
                1706245200
            ],
            [
                3.38,
                1706504400
            ],
            [
                3.23,
                1706590800
            ],
            [
                3.13,
                1706677200
            ],
            [
                3.19,
                1706763600
            ],
            [
                3.18,
                1706850000
            ],
            [
                3.12,
                1707109200
            ],
            [
                3.34,
                1707195600
            ],
            [
                3.24,
                1707282000
            ],
            [
                3.23,
                1707368400
            ],
            [
                3.3,
                1707454800
            ],
            [
                3.39,
                1707714000
            ],
            [
                3.18,
                1707800400
            ],
            [
                3.4,
                1707886800
            ],
            [
                3.6,
                1707973200
            ],
            [
                3.59,
                1708059600
            ],
            [
                3.44,
                1708405200
            ],
            [
                3.35,
                1708491600
            ],
            [
                3.54,
                1708578000
            ],
            [
                3.49,
                1708664400
            ]
        ],
        "statuses": []
    }
]

